Evidence map›Paper›PMID 32969900›Full record

ArticleClinical nuclear medicine2020

18F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET.

Tadashi Watabe, Hiroaki Shimamoto, Sadahiro Naka, Takashi Kamiya, Shumei Murakami

Open access · hybridAbstract readCase ReportsComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical nuclear medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. CD98 Light Chain LAT1 Tracers in PET-CT Diagnosis of Cancer Patients.Anti-cancer agents in medicinal chemistry · 2026
    Review
  2. Review
  3. Review
  4. Sarcoidosis Mimicking Primary Lung Cancer onDiagnostics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tadashi Watabe
Hiroaki ShimamotoDepartment of Oral and Maxillofacial Radiology, Graduate School of Dentistry, Osaka University.
Sadahiro NakaDepartment of Radiology, Osaka University Hospital, Osaka University, Suita, Japan.
Takashi KamiyaDepartment of Radiology, Osaka University Hospital, Osaka University, Suita, Japan.
Shumei MurakamiDepartment of Oral and Maxillofacial Radiology, Graduate School of Dentistry, Osaka University.
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 68-year-old man with sarcoidosis showed high F-FDG uptake in the mediastinal and hilar lymph nodes on F-FDG PET, suggesting active inflammation. F-fluoro-boronophenylalanine (FBPA) PET showed no significant uptake in the mediastinal and hilar lymph nodes, suggesting its cancer specificity as a substrate of L-type amino acid transporter 1. F-fluoro-boronophenylalanine PET can be used for precise evaluation in oncology when the differentiation between inflammation and metastasis is inconclusive on F-FDG PET.

Indexed as

Positron-Emission TomographyAgedBiological TransportFluorodeoxyglucose F18HumansInflammationLarge Neutral Amino Acid-Transporter 1MaleSarcoidosisSensitivity and SpecificityFluorodeoxyglucose F18Large Neutral Amino Acid-Transporter 1

Identifiers

PMID32969900
PMCPMC7531499
OpenAlexW3089257295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.